🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple myeloma (MM) is a plasma cell disease characterized by the growth ...
Status
Recruiting
Location
University of Southern California /ID# 272414
Start Date
2025-07-23
Trial ID
NCT06953960
Treatments Being Tested
This phase II trial studies how well daratumumab, azacitidine, and dexameth...
Status
Terminated
Location
University of California, San Francisco
Start Date
2020-11-30
Trial ID
NCT04407442
Treatments Being Tested
This is a Phase 3, randomized (study drug assigned by chance), open-label (...
Status
Active Not Recruiting
Location
Chru Jean Minjoz
Start Date
2019-10-17
Trial ID
NCT03993912
This study is being done to find out whether carfilzomib, lenalidomide, and...
Status
Active Not Recruiting
Location
University of Miami
Start Date
2020-02-11
Trial ID
NCT04268498
The purpose of this study is to compare the efficacy of daratumumab in comb...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-16
Trial ID
NCT02252172
Treatments Being Tested
This phase I/II trial tests the safety, side effects, and best dose of vene...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-01-08
Trial ID
NCT05486481
The purpose of this study is to test whether Daratumumab-SC, a drug that el...
Status
Completed
Location
Stanford Health Care
Start Date
2021-07-01
Trial ID
NCT04610320
Treatments Being Tested
The DARA-MVI Study is a prospective, randomized, controlled, open-label tri...
Status
Active Not Recruiting
Location
Transplant-nephrology department
Start Date
2025-11-01
Trial ID
NCT07274462
Treatments Being Tested
The purpose of this study is to characterize cardiac safety of Daratumumab,...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2022-03-01
Trial ID
NCT05250973
Treatments Being Tested
This is a multicenter, open-label phase II study with 2 parallel cohorts fo...
Status
Recruiting
Location
IT-Ascoli Piceno-Ospedale Mazzoni [01-016]
Start Date
2025-12-12
Trial ID
NCT07107529
Treatments Being Tested